Home › Funds › Two Sigma Investments › IFRX
Two Sigma Investments position in IFRX
INFLARX NV · Health Care
Latest position (Q2 2026)181.12K sh
Reported value held$405.70K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 11.07K | $29.00K | New |
| Q4 2021 | 60.17K | $286.00K | Add |
| Q1 2022 | 49.23K | $90.00K | Reduce |
| Q3 2023 | 12.43K | $37.03K | New |
| Q4 2023 | 138.38K | $225.55K | Add |
| Q1 2024 | 102.22K | $157.41K | Reduce |
| Q2 2024 | 51.54K | $89.68K | Reduce |
| Q3 2024 | 24.01K | $36.74K | Reduce |
| Q4 2024 | 19.72K | $48.70K | Reduce |
| Q4 2025 | 406.31K | $410.38K | New |
| Q1 2026 | 189.07K | $169.11K | Reduce |
| Q2 2026 | 181.12K | $405.70K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IFRX
- Fidelity Management & Research (FMR) 8.16M sh · $18.29M · Q2 2026
- Farallon Capital Management 3.33M sh · $7.45M · Q2 2026
- Franklin Resources 1.04M sh · $2.32M · Q2 2026
- Morgan Stanley 915.61K sh · $2.05M · Q2 2026
- Marshall Wace 711.30K sh · $1.59M · Q2 2026
- Millennium Management 567.05K sh · $1.27M · Q2 2026
- UBS Group AG 79.13K sh · $177.26K · Q2 2026
- Invesco Ltd 43.85K sh · $98.23K · Q2 2026
- Geode Capital Management 43.67K sh · $97.83K · Q2 2026
- Citadel Advisors 12.80K sh · $28.67K · Q2 2026
- JPMorgan Chase & Co 3.22K sh · $7.35K · Q2 2026